Immutep (IMMP) Common Equity (2011 - 2025)
Immutep (IMMP) posted Common Equity of $64.9 million for Q4 2025, down 29.41% on a QoQ basis from $92.0 million in Q2 2025, and down 42.43% year-over-year from $112.8 million in Q4 2024.
Immutep (IMMP) Common Equity (2011 - 2025) Analysis & Trends
Immutep's Common Equity history runs 15 years deep, the most recent figure standing at $64.9 million for Q4 2025.
- Quarterly Common Equity fell 42.43% year-over-year to $64.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $64.9 million (down 42.43% YoY) and the FY2025 annual result came in at $92.0 million, down 26.35% from the prior year.
- Common Equity was $64.9 million for Q4 2025 at Immutep, down from $92.0 million in the prior quarter.
- Across five years, Common Equity topped out at $124.9 million in Q2 2024 and bottomed at $50.4 million in Q4 2022.
- A 5-year average of $81.5 million and a median of $77.3 million in 2021 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2021 — Common Equity jumped 158.52% — and 2025, when it slumped 42.43%.
- Immutep's Common Equity stood at $79.3 million in 2021, then sank by 36.48% to $50.4 million in 2022, then soared by 49.41% to $75.3 million in 2023, then jumped by 49.82% to $112.8 million in 2024, then slumped by 42.43% to $64.9 million in 2025.
- Business Quant data shows IMMP's Common Equity at $64.9 million in Q4 2025, $92.0 million in Q2 2025, and $112.8 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Immutep | 567.77 Mn | 567.77 Mn | - | 64.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 64.93 Mn |
| Jun 30, 2025 | 91.99 Mn |
| Dec 31, 2024 | 112.79 Mn |
| Jun 30, 2024 | 124.90 Mn |
| Dec 31, 2023 | 75.28 Mn |
| Jun 30, 2023 | 91.21 Mn |
| Dec 31, 2022 | 50.39 Mn |
| Jun 30, 2022 | 67.38 Mn |
| Dec 31, 2021 | 79.32 Mn |
| Jun 30, 2021 | 56.42 Mn |
| Dec 31, 2020 | 44.36 Mn |
| Jun 30, 2020 | 21.83 Mn |
| Dec 31, 2019 | 19.15 Mn |
| Jun 30, 2019 | 17.08 Mn |
| Dec 31, 2018 | 24.05 Mn |
| Jun 30, 2018 | 25.38 Mn |
| Jun 30, 2017 | 19.93 Mn |
| Mar 31, 2017 | 21.56 Mn |
| Jun 30, 2016 | 26.37 Mn |
| Jun 30, 2015 | 19.19 Mn |